Prolonged contact with dendritic cells turns lymph node-resident NK cells into anti-tumor effectors

EMBO Molecular Medicine

Volumn 8, Issue 9, 2016, Pages 1039-1051

  Mingozzi, Francesca ^a   Spreafico, Roberto ^a   Gorletta, Tatiana ^a   Cigni, Clara ^a   Di Gioia, Marco ^b   Caccia, Michele ^a   Sironi, Laura ^a   Collini, Maddalena ^a   Soncini, Matias ^c   Rusconi, Michela ^a   von Andrian, Ulrich H ^d,e   Chirico, Giuseppe ^a   Zanoni, Ivan ^a,b,c   Granucci, Francesca ^a,c  

^a UNIVERSITY OF MILANO BICOCCA   (Italy)

^b BOSTON CHILDREN S HOSPITAL   (United States)

^c HUMANITAS CLINICAL AND RESEARCH CENTER   (Italy)

^d HARVARD MEDICAL SCHOOL   (United States)

^e MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

Author keywords

dendritic cells; immunosurveillance; innate immunity; natural killer cells; two photon microscopy

Indexed keywords

GAMMA INTERFERON; INTERFERON; INTERLEUKIN 12; INTERLEUKIN 15; INTERLEUKIN 15 RECEPTOR ALPHA; INTERLEUKIN 18; LIPOPOLYSACCHARIDE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BYSTANDER EFFECT; CANCER INHIBITION; CELL ACTIVATION; CELL CONTACT; CELL DISTANCE; CELL INTERACTION; CELLULAR DISTRIBUTION; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DENDRITIC CELL; FEMALE; IN VITRO STUDY; IN VIVO STUDY; INFLAMMATION; INNATE IMMUNITY; LYMPH NODE; LYMPHOCYTE ACTIVATION; MOUSE; MULTIPHOTON MICROSCOPY; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; SYNAPSE; TUMOR INVASION; TUMOR VOLUME; TWO PHOTON MICROSCOPY;

EID: 84984850960     PISSN: 17574676     EISSN: 17574684     Source Type: Journal    
DOI: 10.15252/emmm.201506164     Document Type: Article

References (50)

1. Agaugue S, Marcenaro E, Ferranti B, Moretta L, Moretta A (2008) Human natural killer cells exposed to IL-2, IL-12, IL-18, or IL-4 differently modulate priming of naive T cells by monocyte-derived dendritic cells. Blood 112: 1776–1783
2. Barreira da Silva R, Graf C, Munz C (2011) Cytoskeletal stabilization of inhibitory interactions in immunologic synapses of mature human dendritic cells with natural killer cells. Blood 118: 6487–6498
3. Barreira da Silva R, Munz C (2011) Natural killer cell activation by dendritic cells: balancing inhibitory and activating signals. Cell Mol Life Sci 68: 3505–3518
4. Beatty GL, Paterson Y (2000) IFN-gamma can promote tumor evasion of the immune system in vivo by down-regulating cellular levels of an endogenous tumor antigen. J Immunol 165: 5502–5508
5. Beuneu H, Deguine J, Breart B, Mandelboim O, Di Santo JP, Bousso P (2009) Dynamic behavior of NK cells during activation in lymph nodes. Blood 114: 3227–3234
6. Borg C, Jalil A, Laderach D, Maruyama K, Wakasugi H, Charrier S, Ryffel B, Cambi A, Figdor C, Vainchenker W et al (2004) NK cell activation by dendritic cells (DCs) requires the formation of a synapse leading to IL-12 polarization in DCs. Blood 104: 3267–3275
7. Brilot F, Strowig T, Roberts SM, Arrey F, Munz C (2007) NK cell survival mediated through the regulatory synapse with human DCs requires IL-15Ralpha. J Clin Invest 117: 3316–3329
8. Caccia M, Sironi L, Collini M, Chirico G, Zanoni I, Granucci F (2008) Image filtering for two-photon deep imaging of lymphonodes. Eur Biophys J 37: 979–987
9. Carrega P, Bonaccorsi I, Di Carlo E, Morandi B, Paul P, Rizzello V, Cipollone G, Navarra G, Mingari MC, Moretta L et al (2014) CD56(bright)perforin(low) noncytotoxic human NK cells are abundant in both healthy and neoplastic solid tissues and recirculate to secondary lymphoid organs via afferent lymph. J Immunol 192: 3805–3815
10. Chijioke O, Munz C (2013) Dendritic cell derived cytokines in human natural killer cell differentiation and activation. Front Immunol 4: 365
11. Colucci F, Di Santo JP, Leibson PJ (2002) Natural killer cell activation in mice and men: different triggers for similar weapons? Nat Immunol 3: 807–813
12. Curnis F, Gasparri A, Sacchi A, Cattaneo A, Magni F, Corti A (2005) Targeted delivery of IFNgamma to tumor vessels uncouples antitumor from counterregulatory mechanisms. Cancer Res 65: 2906–2913
13. Deng J, Liu X, Rong L, Ni C, Li X, Yang W, Lu Y, Yan X, Qin C, Zhang L et al (2014) IFNgamma-responsiveness of endothelial cells leads to efficient angiostasis in tumours involving down-regulation of Dll4. J Pathol 233: 170–182
14. Desbois M, Rusakiewicz S, Locher C, Zitvogel L, Chaput N (2012) Natural killer cells in non-hematopoietic malignancies. Front Immunol 3: 395
15. Dinarello CA, Novick D, Kim S, Kaplanski G (2013) Interleukin-18 and IL-18 binding protein. Front Immunol 4: 289
16. Fabbi M, Carbotti G, Ferrini S (2015) Context-dependent role of IL-18 in cancer biology and counter-regulation by IL-18BP. J Leukoc Biol 97: 665–675
17. Feng CG, Kaviratne M, Rothfuchs AG, Cheever A, Hieny S, Young HA, Wynn TA, Sher A (2006) NK cell-derived IFN-gamma differentially regulates innate resistance and neutrophil response in T cell-deficient hosts infected with Mycobacterium tuberculosis. J Immunol 177: 7086–7093
18. Ferlazzo G, Pack M, Thomas D, Paludan C, Schmid D, Strowig T, Bougras G, Muller WA, Moretta L, Munz C (2004) Distinct roles of IL-12 and IL-15 in human natural killer cell activation by dendritic cells from secondary lymphoid organs. Proc Natl Acad Sci USA 101: 16606–16611
19. Fernandez NC, Lozier A, Flament C, Ricciardi-Castagnoli P, Bellet D, Suter M, Perricaudet M, Tursz T, Maraskovsky E, Zitvogel L (1999) Dendritic cells directly trigger NK cell functions: cross-talk relevant in innate anti-tumor immune responses in vivo. Nat Med 5: 405–411
20. Figueiredo F, Commodaro AG, de Camargo MM, Rizzo LV, Belfort R Jr (2007) NK1.1 cells downregulate murine endotoxin-induced uveitis following intraocular administration of interleukin-12. Scand J Immunol 66: 329–334
21. Gardella S, Andrei C, Costigliolo S, Poggi A, Zocchi MR, Rubartelli A (1999) Interleukin-18 synthesis and secretion by dendritic cells are modulated by interaction with antigen-specific T cells. J Leukoc Biol 66: 237–241
22. Granucci F, Vizzardelli C, Pavelka N, Feau S, Persico M, Virzi E, Rescigno M, Moro G, Ricciardi-Castagnoli P (2001) Inducible IL-2 production by dendritic cells revealed by global gene expression analysis. Nat Immunol 2: 882–888
23. Granucci F, Zanoni I, Pavelka N, Van Dommelen SL, Andoniou CE, Belardelli F, Degli Esposti MA, Ricciardi-Castagnoli P (2004) A contribution of mouse dendritic cell-derived IL-2 for NK cell activation. J Exp Med 200: 287–295
24. Inaba K, Inaba M, Romani N, Aya H, Deguchi M, Ikehara S, Muramatsu S, Steinman RM (1992) Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte/macrophage colony-stimulating factor. J Exp Med 176: 1693–1702
25. Jenne CN, Enders A, Rivera R, Watson SR, Bankovich AJ, Pereira JP, Xu Y, Roots CM, Beilke JN, Banerjee A et al (2009) T-bet-dependent S1P5 expression in NK cells promotes egress from lymph nodes and bone marrow. J Exp Med 206: 2469–2481
26. Jung S, Unutmaz D, Wong P, Sano G, De los Santos K, Sparwasser T, Wu S, Vuthoori S, Ko K, Zavala F et al (2002) In vivo depletion of CD11c(+) dendritic cells abrogates priming of CD8(+) T cells by exogenous cell-associated antigens. Immunity 17: 211–220
27. Kupz A, Scott TA, Belz GT, Andrews DM, Greyer M, Lew AM, Brooks AG, Smyth MJ, Curtiss R III, Bedoui S et al (2013) Contribution of Thy1+ NK cells to protective IFN-gamma production during Salmonella typhimurium infections. Proc Natl Acad Sci USA 110: 2252–2257
28. Lee HM, Fleige A, Forman R, Cho S, Khan AA, Lin LL, Nguyen DT, O'Hara-Hall A, Yin Z, Hunter CA et al (2015) IFNgamma signaling endows DCs with the capacity to control type I inflammation during parasitic infection through promoting T-bet+ regulatory T cells. PLoS Pathog 11: e1004635
29. Lin IY, Van TT, Smooker PM (2015) Live-attenuated bacterial vectors: tools for vaccine and therapeutic agent delivery. Vaccines 3: 940–972
30. Lu M, Munford RS (2011) The transport and inactivation kinetics of bacterial lipopolysaccharide influence its immunological potency in vivo. J Immunol 187: 3314–3320
31. Lucas M, Schachterle W, Oberle K, Aichele P, Diefenbach A (2007) Dendritic cells prime natural killer cells by trans-presenting interleukin 15. Immunity 26: 503–517
32. Martin-Fontecha A, Thomsen LL, Brett S, Gerard C, Lipp M, Lanzavecchia A, Sallusto F (2004) Induced recruitment of NK cells to lymph nodes provides IFN-gamma for T(H)1 priming. Nat Immunol 5: 1260–1265
33. Matloubian M, Lo CG, Cinamon G, Lesneski MJ, Xu Y, Brinkmann V, Allende ML, Proia RL, Cyster JG (2004) Lymphocyte egress from thymus and peripheral lymphoid organs is dependent on S1P receptor 1. Nature 427: 355–360
34. Mattiola I, Pesant M, Tentorio PF, Molgora M, Marcenaro E, Lugli E, Locati M, Mavilio D (2015) Priming of human resting NK Cells by autologous M1 macrophages via the engagement of IL-1beta, IFN-beta, and IL-15 pathways. J Immunol 195: 2818–2828
35. Mayer K, Birnbaum F, Reinhard T, Reis A, Braunstein S, Claas F, Sundmacher R (2004) FTY720 prolongs clear corneal allograft survival with a differential effect on different lymphocyte populations. Br J Ophthalmol 88: 915–919
36. Miller MJ, Wei SH, Parker I, Cahalan MD (2002) Two-photon imaging of lymphocyte motility and antigen response in intact lymph node. Science 296: 1869–1873
37. Moretta L, Montaldo E, Vacca P, Del Zotto G, Moretta F, Merli P, Locatelli F, Mingari MC (2014) Human natural killer cells: origin, receptors, function, and clinical applications. Int Arch Allergy Immunol 164: 253–264
38. Newman KC, Riley EM (2007) Whatever turns you on: accessory-cell-dependent activation of NK cells by pathogens. Nat Rev Immunol 7: 279–291
39. Rush CM, Millington OR, Hutchison S, Bryson K, Brewer JM, Garside P (2009) Characterization of CD4+ T-cell-dendritic cell interactions during secondary antigen exposure in tolerance and priming. Immunology 128: 463–471
40. Schindelin J, Arganda-Carreras I, Frise E, Kaynig V, Longair M, Pietzsch T, Preibisch S, Rueden C, Saalfeld S, Schmid B et al (2012) Fiji: an open-source platform for biological-image analysis. Nat Methods 9: 676–682
41. Schindelin J, Rueden CT, Hiner MC, Eliceiri KW (2015) The ImageJ ecosystem: an open platform for biomedical image analysis. Mol Reprod Dev 82: 518–529
42. Semino C, Angelini G, Poggi A, Rubartelli A (2005) NK/iDC interaction results in IL-18 secretion by DCs at the synaptic cleft followed by NK cell activation and release of the DC maturation factor HMGB1. Blood 106: 609–616
43. Sims TN, Dustin ML (2002) The immunological synapse: integrins take the stage. Immunol Rev 186: 100–117
44. Skrombolas D, Frelinger JG (2014) Challenges and developing solutions for increasing the benefits of IL-2 treatment in tumor therapy. Exp Rev Clin Immunol 10: 207–217
45. Thompson DB, Siref LE, Feloney MP, Hauke RJ, Agrawal DK (2015) Immunological basis in the pathogenesis and treatment of bladder cancer. Exp Rev Clin Immunol 11: 265–279
46. Toussaint B, Chauchet X, Wang Y, Polack B, Le Gouellec A (2013) Live-attenuated bacteria as a cancer vaccine vector. Expert Rev Vaccines 12: 1139–1154
47. Villa CE, Caccia M, Sironi L, D'Alfonso L, Collini M, Rivolta I, Miserocchi G, Gorletta T, Zanoni I, Granucci F et al (2010) Accumulative difference image protocol for particle tracking in fluorescence microscopy tested in mouse lymphonodes. PLoS One 5: e12216
48. Wu HJ, Sawaya H, Binstadt B, Brickelmaier M, Blasius A, Gorelik L, Mahmood U, Weissleder R, Carulli J, Benoist C et al (2007) Inflammatory arthritis can be reined in by CpG-induced DC-NK cell cross talk. J Exp Med 204: 1911–1922
49. Zanoni I, Foti M, Ricciardi-Castagnoli P, Granucci F (2005) TLR-dependent activation stimuli associated with Th1 responses confer NK cell stimulatory capacity to mouse dendritic cells. J Immunol 175: 286–292
50. Zanoni I, Spreafico R, Bodio C, Di Gioia M, Cigni C, Broggi A, Gorletta T, Caccia M, Chirico G, Sironi L et al (2013) IL-15 cis presentation is required for optimal NK cell activation in lipopolysaccharide-mediated inflammatory conditions. Cell Rep 4: 1235–1249